Related Experiment Videos
[Plasma volume in polycystic kidney disease]
Sbornik Lekarsky
|January 1, 1994
Summary
Hypertension in autosomal dominant polycystic kidney disease (ADPKD) is not linked to increased plasma and blood volume (PV and BV) early on. This study found no significant PV or BV changes before hypertension onset in ADPKD patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Genetics
Context:
- Autosomal dominant polycystic kidney disease (ADPKD) frequently leads to early-onset hypertension.
- Sodium transport disorders and volume expansion are hypothesized contributors to ADPKD hypertension.
- Understanding early volume status is crucial for managing ADPKD complications.
Purpose:
- To investigate plasma volume (PV) and blood volume (BV) in patients with early-stage ADPKD.
- To determine if increased PV and BV precede or contribute to hypertension in ADPKD.
- To compare volume status between hypertensive ADPKD, normotensive ADPKD, and healthy individuals.
Summary:
- Plasma volume (PV) and blood volume (BV) were measured using radioactive serum albumin dilution in three groups: ADPKD hypertensive, ADPKD normotensive, and healthy controls, all with normal glomerular filtration rate.
- When normalized for body surface area, a diminished blood volume (BV) was observed in the hypertensive ADPKD group compared to normotensive ADPKD patients and controls (p < 0.05).
- No significant differences in PV or BV were found when expressed per kilogram of body weight, and other parameters did not differ between groups.
Impact:
- The findings challenge the prevailing hypothesis that increased plasma and blood volume are key drivers of hypertension in early ADPKD.
- Suggests that other pathophysiological mechanisms may be more significant in the development of hypertension in ADPKD.
- Provides valuable data for refining therapeutic strategies targeting volume regulation in ADPKD patients.